217 related articles for article (PubMed ID: 32448741)
21. Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era.
Garcia C; Flamen P
Curr Opin Oncol; 2008 May; 20(3):275-9. PubMed ID: 18391626
[TBL] [Abstract][Full Text] [Related]
22. 18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours.
De Maeseneer DJ; Lambert B; Surmont V; Geboes K; Rottey SW
Acta Clin Belg; 2010; 65(5):291-9. PubMed ID: 21128554
[TBL] [Abstract][Full Text] [Related]
23.
Ohri N; Bodner WR; Halmos B; Cheng H; Perez-Soler R; Keller SM; Kalnicki S; Garg M
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):372-380. PubMed ID: 28068244
[TBL] [Abstract][Full Text] [Related]
24. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
[TBL] [Abstract][Full Text] [Related]
25. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
26. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
[TBL] [Abstract][Full Text] [Related]
27.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
28. Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
Ioffe YJ; Massad LS; Powell MA; Hagemann AR; Mutch DG; Thaker PH; Schwarz JK; Grigsby PW
Gynecol Obstet Invest; 2018; 83(1):83-89. PubMed ID: 28399524
[TBL] [Abstract][Full Text] [Related]
29. Monitoring chemotherapy and radiotherapy of solid tumors.
Weber WA; Wieder H
Eur J Nucl Med Mol Imaging; 2006 Jul; 33 Suppl 1():27-37. PubMed ID: 16688451
[TBL] [Abstract][Full Text] [Related]
30. Role of interim
Cremonesi M; Gilardi L; Ferrari ME; Piperno G; Travaini LL; Timmerman R; Botta F; Baroni G; Grana CM; Ronchi S; Ciardo D; Jereczek-Fossa BA; Garibaldi C; Orecchia R
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1915-1927. PubMed ID: 28681192
[TBL] [Abstract][Full Text] [Related]
31. It's About Quality, Not Quantity: Qualitative FDG PET/CT Criteria for Therapy Response Assessment in Clinical Practice.
Banks KP; Peacock JG; Gusman M; Clemenshaw MN
AJR Am J Roentgenol; 2020 Aug; 215(2):313-324. PubMed ID: 32551905
[No Abstract] [Full Text] [Related]
32. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
[TBL] [Abstract][Full Text] [Related]
33. Methods to delineate tumour for radiotherapy by fluorodeoxyglucose positron emission tomography.
Gardin I
Cancer Radiother; 2020 Aug; 24(5):418-422. PubMed ID: 32507519
[TBL] [Abstract][Full Text] [Related]
34. The role of PET in target localization for radiotherapy treatment planning.
Rembielak A; Price P
Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
[TBL] [Abstract][Full Text] [Related]
35. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
[TBL] [Abstract][Full Text] [Related]
38. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
[TBL] [Abstract][Full Text] [Related]
39. Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.
McKay MJ; Taubman KL; Foroudi F; Lee ST; Scott AM
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):783-791. PubMed ID: 30353883
[TBL] [Abstract][Full Text] [Related]
40. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
